Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: tipifarnib

Sponsor

National Cancer Institute (NCI)